Herpes Cure And Treatment

Acyclovir Dosage Suppression Therapy

Detailed Acyclovir dosage information for adults and children. The safety and efficacy of daily acyclovir suppressive therapy have been documented among patients treated orally for up to six years.

Genital Herpes: ZOVIRAX (acyclovir) is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. The dose for acyclovir for suppressive therapy is 400mg 2x/day. I have no idea why you are on such a high dose. It’s completely unneccesary.

Zovirax (acyclovir) Drug Information: Indications, Dosage And How Supplied

Acyclovir therapy remains an effective and often less expensive option. Famciclovir and valacyclovir offer improved oral bioavailability and convenient oral dosing schedules but are more expensive than acyclovir. Suppressive therapy in these patients is intended to reduce the frequency and severity of herpes symptoms, decrease the transmission of HSV to sexual partners and infants of infected mothers, and decrease the transmission of associated viral diseases (i. Potential subjects who had been receiving suppressive antiviral therapy were required to have had a history of 6 recurrences in the year before initiating suppressive therapy, and 2 recurrences within 3 months of discontinuing suppressive therapy. Our study showed that high-dose episodic therapy with acyclovir for recurrent genital herpes is effective even if it is administered for only 2 days. The projected area under the curve of a 500-mg twice-a-day dose of valacyclovir is 3 times greater than that of a 400-mg twice-a-day dose of oral acyclovir 7. Patients who had been receiving recent suppressive therapy were eligible if they reported 6 recurrencesyear before initiating suppressive therapy.

Acyclovir, valacyclovir, and famciclovir are all used for long-term suppressive therapy. However, only valacyclovir shows a dosing schedule advantage (once rather than twice daily) over acyclovir. In this treatment method, the patient will take a daily dosage of acyclovir or valacyclovir either once or twice daily. What should a person on suppressive therapy do if an outbreak occurs? First, the patient should not panic. Duration of suppressive therapy was 6 months. Valacyclovir (Valtrex) is indicated for: treatment or suppression of genital herpes and for the suppression of recurrent genital herpes treatment of initial genital herpes: 1 gram twice daily for 10 days. It remains active in the body longer than acyclovir (half the dose is still active after 10 to 20 hours) and, like valacyclovir, requires less frequent dosing (usually two or three times a day). Question 12: Is it recommended to give suppressive therapy for asymptomatic HSV?

Genital Herpes Suppressive Treatment In Pregnancy

Since the medicine is not fully in my system, could I up my dosage since Im having an outbreak or will it go away if I just keep taking the 400mg twice a day? When you get a break through ob while on suppressive therapy with acyclovir, , you increase it to 400mg 3xday for 5 days or 800mg 3xday for 2 days then return to your usual twice daily dose. Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS. To study the use of acyclovir (ACV) and zidovudine (AZT) in the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS who would otherwise be treated with ganciclovir (DHPG) alone. During suppression therapy there is no evidence that acyclovir prevents neural migration of the virus. In the absence of suppressive antiviral therapy, the median recurrence rate after the first episode of HSV-2 infection is about four recurrences a year, with about 40 percent of patients having at least six recurrences and 20 percent having more than 10 recurrences in the first year 1, 3. A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections. In response to the concern about possible relapse after the discontinuation of oral acyclovir, in our placebo-controlled study, we did not see any evidence of neurologic relapse after the cessation of active suppressive therapy.


Real Time Web Analytics
Scroll To Top